Aspire Biopharma Holdings, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for Aspire Biopharma Holdings, Inc. (ASBP) is -0.93

According to Aspire Biopharma Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.93. This represents a change of -96.55% compared to the average of -26.94 of the last 4 quarters.

Aspire Biopharma Holdings, Inc. (ASBP) Historical PE Ratio (quarterly & annually)

How has ASBP PE Ratio performed in the past?

The mean historical PE Ratio of Aspire Biopharma Holdings, Inc. over the last ten years is -63487.41. The current -0.93 PE Ratio has changed -99.85% with respect to the historical average. Over the past ten years (40 quarters), ASBP's PE Ratio was at its highest in in the June 2022 quarter at 23.03K. The PE Ratio was at its lowest in in the December 2021 quarter at -2724545.45.

Aspire Biopharma Holdings, Inc. (ASBP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aspire Biopharma Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aspire Biopharma Holdings, Inc. (ASBP) Average PE Ratio

How has ASBP PE Ratio performed in the past?

The current PE Ratio of Aspire Biopharma Holdings, Inc. (ASBP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aspire Biopharma Holdings, Inc. (ASBP) PE Ratio vs. Peers

How is ASBP’s PE Ratio compared to its peers?

Aspire Biopharma Holdings, Inc.’s PE Ratio is greater than Consilium Acquisition Corp I, Ltd. (-7.39), less than AleAnna, Inc. (20.25), greater than Catcha Investment Corp (-18.94), less than Focus Impact Acquisition Corp. (14.80), greater than Golden Arrow Merger Corp. (-2.80), less than Collective Audience, Inc. (-0.00), less than LIV Capital Acquisition Corp. II (416.70), less than Blue Ocean Acquisition Corp. (47.52), greater than Insight Acquisition Corp. (-27.14), greater than Integrated Wellness Acquisition Corp (-12.57),

Build a custom stock screener for Aspire Biopharma Holdings, Inc. (ASBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspire Biopharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aspire Biopharma Holdings, Inc. (ASBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aspire Biopharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.